Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to enhance healthcare delivery.
In September 2024, the European Commission (EC) granted marketing authorization for an updated formulation of Moderna's COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1, for ...
13d
Hosted on MSNModerna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week HighShares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...
Moderna, Inc. announced that it has been awarded a tender for the supply of its mRNA Covid-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting agreement, 17 ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
Europe preventive vaccines market was valued at $18.02 billion ... rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Request To Download Free ...
The US president signed a series of executive orders to remove diversity, equity and inclusion from the military, reinstate thousands of troops who were kicked out for refusing COVID vaccines, and ...
13d
Investor's Business Daily on MSNModerna Yo-Yos After European Officials Ink Supply Deal For Covid ShotsModerna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.
Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results